Lansing

The trials here

What the 2 trials at this site are about, from their registry records.

Phase

• Phase 31 trial

Status

• Completed1 trial
• Enrolling by invitation1 trial

Lead sponsor

• Soleno Therapeutics, Inc.2 trials

Running trials

• Enrolling by invitation

  Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome

  NCT07450664· Soleno Therapeutics, Inc.· Source

Closed trials

• Completed

  Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome

  NCT05701774· Phase 3· Soleno Therapeutics, Inc.· Source